Literature DB >> 15818511

Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.

Ou Jin1, Ling-yun Sun, Kang-xin Zhou, Xin-su Zhang, Xue-bing Feng, Mo-yin Mok, Chak-sing Lau.   

Abstract

Increased lymphocyte apoptosis and defects in macrophage removal of apoptotic cells have been suggested to contribute to the development of systemic lupus erythematosus (SLE). The aim of this study was to investigate the relationship between peripheral lymphocyte apoptosis, macrophage function as determined by the serum levels of neopterin and interferon-gamma (IFN-gamma), and SLE disease activity. Peripheral apoptotic lymphocytes (AL) were detected by annexin V-fluorescein isothiocyanate (FITC) staining and flow cytometry. Serum levels of neopterin and IFN-gamma were measured by enzyme-linked immunosorbent assay (ELISA). SLE disease activity was determined using the systemic lupus activity measure (SLAM) and the serum titer of anti-dsDNA antibodies. The percentage of AL in the peripheral blood of active SLE patients was significantly higher (13.07+/-7.39%, n=30) than that of the inactive SLE patients (4.08+/-3.55%, n=8, p<0.01) and normal controls (5.13+/-3.37%, n=11, p<0.01). Serum levels of neopterin in active SLE patients were significantly higher (1.39+/-1.10 microg/dl, n=22) than in controls (0.26+/-0.19 microg/dl, n=20, p<0.01). Serum levels of IFN-gamma in active SLE patients were elevated (58.97+/-34.52 ng/l, n=15) when compared with controls (28.06+/-2.35 ng/l, n=16, p<0.05). The percentage of AL correlated significantly with serum levels of neopterin (r=0.446, p<0.05, n=22) and SLAM score (r=0.533, p<0.001, n=38), but not with the serum levels of IFN-gamma. The SLAM score also correlated with the serum levels of neopterin (r=0.485, p<0.05, n=22), but not with those of IFN-gamma. Our study supported the hypothesis that increased lymphocyte apoptosis has a pathogenic role in SLE. The increased levels of serum neopterin may suggest an attempt of the patients' macrophage system to remove the apoptotic cell excess. Since serum levels of neopterin correlated with the overall lupus disease activity, they may be regarded as an index of SLE disease activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15818511     DOI: 10.1007/s10067-004-0972-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Role of apoptosis in autoimmunity.

Authors:  H M Lorenz; M Herrmann; T Winkler; U Gaipl; J R Kalden
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

2.  High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.

Authors:  A Perniok; F Wedekind; M Herrmann; C Specker; M Schneider
Journal:  Lupus       Date:  1998       Impact factor: 2.911

Review 3.  Neopterin measurement in clinical diagnosis.

Authors:  A Berdowska; K Zwirska-Korczala
Journal:  J Clin Pharm Ther       Date:  2001-10       Impact factor: 2.512

4.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.

Authors:  W Emlen; J Niebur; R Kadera
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

5.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; O M Zoller; M Hagenhofer; B B Ponner; J R Kalden
Journal:  Arthritis Rheum       Date:  1998-07

8.  A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.

Authors:  P R Taylor; A Carugati; V A Fadok; H T Cook; M Andrews; M C Carroll; J S Savill; P M Henson; M Botto; M J Walport
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

9.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  20 in total

Review 1.  Apoptotic cell death and lupus.

Authors:  Philip L Cohen
Journal:  Springer Semin Immunopathol       Date:  2006-08-29

2.  Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.

Authors:  Dhanesh Pitidhammabhorn; Surasak Kantachuvesiri; Kitti Totemchokchyakarn; Yindee Kitiyanant; Sukathida Ubol
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

3.  Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus.

Authors:  E Pieterse; J Hofstra; J Berden; M Herrmann; J Dieker; J van der Vlag
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

4.  Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern.

Authors:  Reza Saghiri; Niloufar Ghashghai; Shafieh Movaseghi; Pegah Poursharifi; Shohreh Jalilfar; Manijeh Ahmadi Bidhendi; Leila Ghazizadeh; Mina Ebrahimi-Rad
Journal:  Rheumatol Int       Date:  2011-02-25       Impact factor: 2.631

5.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

Review 6.  Anti-TNF-alpha therapies in systemic lupus erythematosus.

Authors:  Lang-Jing Zhu; Xiao Yang; Xue-Qing Yu
Journal:  J Biomed Biotechnol       Date:  2010-06-22

7.  Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.

Authors:  Gang Chen; Feng-jiang Zhang; Ming Gong; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

Review 8.  Dendritic cells and the immunopathogenesis of systemic lupus erythematosus.

Authors:  Seetha Monrad; Mariana J Kaplan
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity.

Authors:  Yang Li; Li-dan Zhao; Lu-sha Tong; Su-ning Qian; Yan Ren; Lei Zhang; Xin Ding; Yang Chen; Yan-xia Wang; Wen Zhang; Xiao-feng Zeng; Feng-chun Zhang; Fu-lin Tang; Xuan Zhang; De-nian Ba; Wei He; Xue-tao Cao; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2012-05-23       Impact factor: 5.156

10.  Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.

Authors:  Langjing Zhu; Xiao Yang; Weiying Chen; Xiaoyan Li; Yulian Ji; Haiping Mao; Jing Nie; Xueqing Yu
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.